Publications by authors named "Jason Lukas"

Claim this Profile
S
Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer.
R Connor Chick, G Travis Clifton, Diane F Hale, Timothy J Vreeland, Annelies T Hickerson, Jason Lukas

Clin Immunol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer.
G Travis Clifton, Diane Hale, Timothy J Vreeland, Annelies T Hickerson, Jennifer K Litton, Jason J Lukas

Clin Cancer Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial safety analysis of a randomized phase II trial of nelipepimut-S + GM-CSF and trastuzumab compared to trastuzumab alone to prevent recurrence in breast cancer patients with HER2 low-expressing tumors.
G Travis Clifton, Kaitlin M Peace, Jarrod P Holmes, Timothy J Vreeland, Diane F Hale, Jason Lukas

Clin Immunol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The major reverse transcriptase-incompetent splice variant of the human telomerase protein inhibits telomerase activity but protects from apoptosis.
Imke Listerman, Jie Sun, Francesca S Gazzaniga, Jason L Lukas, Elizabeth H Blackburn

Cancer Res· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice.
Keith L Knutson, Yushe Dang, Hailing Lu, Jason Lukas, Bond Almand

J Immunol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nucleic acid molecular biomarkers for diagnostic biodosimetry applications: use of the fluorogenic 5'-nuclease polymerase chain reaction assay.
William F Blakely, Alexandra C Miller, Lei Luo, Jason Lukas, Zachary D Hornby

Mil Med· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis